The University of Chicago Medicine was the first health system in Illinois to treat patients with histotripsy, a new noninvasive technology that uses ultrasound energy to precisely destroy liver tumors.
UChicago Medicine has been involved for years in bringing histotripsy to patients, having treated patients in the U.S. arm of the #HOPE4LIVER clinical trial. Histotripsy technology received FDA approval in October 2023, and UChicago Medicine physicians expect to begin clinical implementation in early 2024. READ MORE
